Concepts (215)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proctocolectomy, Restorative | 13 | 2016 | 87 | 1.460 |
Why?
|
| Crohn Disease | 16 | 2015 | 730 | 1.400 |
Why?
|
| Colitis, Ulcerative | 15 | 2017 | 711 | 1.150 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 4 | 2015 | 243 | 0.980 |
Why?
|
| Aspirin | 3 | 2015 | 156 | 0.960 |
Why?
|
| Intestinal Mucosa | 7 | 2015 | 797 | 0.830 |
Why?
|
| Postoperative Complications | 20 | 2014 | 2207 | 0.830 |
Why?
|
| Colonic Pouches | 8 | 2016 | 67 | 0.810 |
Why?
|
| Laparoscopy | 10 | 2014 | 754 | 0.740 |
Why?
|
| Colectomy | 9 | 2014 | 167 | 0.650 |
Why?
|
| Intestinal Obstruction | 4 | 2015 | 88 | 0.630 |
Why?
|
| Mannitol | 3 | 2015 | 49 | 0.580 |
Why?
|
| Lactulose | 3 | 2015 | 19 | 0.580 |
Why?
|
| Digestive System Surgical Procedures | 6 | 2013 | 120 | 0.580 |
Why?
|
| Intestinal Absorption | 2 | 2014 | 124 | 0.570 |
Why?
|
| Constriction, Pathologic | 5 | 2015 | 213 | 0.560 |
Why?
|
| Carbohydrates | 1 | 2014 | 47 | 0.480 |
Why?
|
| Rectum | 4 | 2014 | 146 | 0.460 |
Why?
|
| Rectal Neoplasms | 3 | 2014 | 116 | 0.400 |
Why?
|
| Perineum | 3 | 2014 | 35 | 0.370 |
Why?
|
| Anastomosis, Surgical | 7 | 2011 | 267 | 0.360 |
Why?
|
| Inflammatory Bowel Diseases | 5 | 2014 | 549 | 0.340 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 579 | 0.340 |
Why?
|
| Adult | 33 | 2017 | 25640 | 0.330 |
Why?
|
| Follow-Up Studies | 15 | 2017 | 3636 | 0.330 |
Why?
|
| Prospective Studies | 18 | 2016 | 4210 | 0.320 |
Why?
|
| Smoking | 1 | 2012 | 609 | 0.320 |
Why?
|
| Anal Canal | 4 | 2011 | 89 | 0.290 |
Why?
|
| Permeability | 4 | 2015 | 137 | 0.280 |
Why?
|
| Preoperative Care | 2 | 2014 | 394 | 0.250 |
Why?
|
| Female | 36 | 2017 | 44507 | 0.250 |
Why?
|
| Neoplasm, Residual | 1 | 2005 | 162 | 0.250 |
Why?
|
| Pouchitis | 2 | 2008 | 44 | 0.240 |
Why?
|
| Anus Diseases | 2 | 2015 | 14 | 0.230 |
Why?
|
| Urine | 2 | 2014 | 90 | 0.220 |
Why?
|
| Male | 33 | 2017 | 40956 | 0.220 |
Why?
|
| Ileal Diseases | 2 | 2007 | 25 | 0.220 |
Why?
|
| Adenomatous Polyposis Coli | 2 | 2000 | 39 | 0.220 |
Why?
|
| Humans | 42 | 2017 | 86601 | 0.210 |
Why?
|
| Middle Aged | 23 | 2017 | 25017 | 0.210 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 1685 | 0.200 |
Why?
|
| Reoperation | 8 | 2013 | 597 | 0.200 |
Why?
|
| Colorectal Neoplasms | 4 | 2017 | 938 | 0.200 |
Why?
|
| Treatment Outcome | 15 | 2014 | 7988 | 0.190 |
Why?
|
| Adenocarcinoma | 2 | 2005 | 1169 | 0.190 |
Why?
|
| Ileostomy | 3 | 2011 | 30 | 0.180 |
Why?
|
| Surgical Flaps | 1 | 2001 | 241 | 0.170 |
Why?
|
| Surgical Stapling | 3 | 2008 | 17 | 0.160 |
Why?
|
| Defecation | 3 | 2008 | 23 | 0.160 |
Why?
|
| Time Factors | 7 | 2013 | 5209 | 0.160 |
Why?
|
| Recurrence | 6 | 2010 | 1139 | 0.160 |
Why?
|
| Thrombospondins | 1 | 2017 | 14 | 0.160 |
Why?
|
| Intraoperative Complications | 2 | 1997 | 185 | 0.160 |
Why?
|
| Caveolin 1 | 1 | 2017 | 20 | 0.160 |
Why?
|
| Aged | 14 | 2016 | 18402 | 0.150 |
Why?
|
| Venous Thrombosis | 2 | 2014 | 243 | 0.150 |
Why?
|
| Quality of Life | 6 | 2014 | 1583 | 0.150 |
Why?
|
| Collagen Type I | 1 | 2017 | 62 | 0.150 |
Why?
|
| Adolescent | 11 | 2016 | 8979 | 0.150 |
Why?
|
| Focal Adhesions | 1 | 2017 | 69 | 0.150 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2015 | 315 | 0.140 |
Why?
|
| Suture Techniques | 4 | 2008 | 135 | 0.140 |
Why?
|
| Ostomy | 1 | 2015 | 15 | 0.140 |
Why?
|
| Intestinal Fistula | 1 | 2015 | 30 | 0.140 |
Why?
|
| Ascorbic Acid | 1 | 2015 | 37 | 0.130 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2014 | 18 | 0.120 |
Why?
|
| Rhamnose | 1 | 2014 | 4 | 0.120 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 191 | 0.120 |
Why?
|
| Intestine, Small | 5 | 2015 | 303 | 0.120 |
Why?
|
| Clostridium Infections | 1 | 2016 | 125 | 0.120 |
Why?
|
| Portal Vein | 1 | 2014 | 120 | 0.120 |
Why?
|
| Hernia, Femoral | 1 | 1992 | 2 | 0.110 |
Why?
|
| Colitis | 2 | 2007 | 239 | 0.110 |
Why?
|
| Ascites | 1 | 1992 | 55 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2017 | 534 | 0.110 |
Why?
|
| Young Adult | 5 | 2016 | 5974 | 0.110 |
Why?
|
| Retrospective Studies | 10 | 2016 | 8475 | 0.110 |
Why?
|
| Risk Factors | 6 | 2014 | 5416 | 0.100 |
Why?
|
| Hernia, Inguinal | 1 | 1992 | 67 | 0.100 |
Why?
|
| Mesenteric Veins | 2 | 2014 | 34 | 0.100 |
Why?
|
| Microbiota | 1 | 2016 | 381 | 0.100 |
Why?
|
| Intestines | 2 | 2011 | 411 | 0.090 |
Why?
|
| Chi-Square Distribution | 4 | 2010 | 364 | 0.090 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 1990 | 0.090 |
Why?
|
| Obesity, Morbid | 1 | 2013 | 225 | 0.090 |
Why?
|
| Length of Stay | 3 | 2013 | 700 | 0.090 |
Why?
|
| Transcriptome | 1 | 2013 | 580 | 0.080 |
Why?
|
| Robotics | 1 | 2011 | 267 | 0.080 |
Why?
|
| Abscess | 2 | 2014 | 91 | 0.080 |
Why?
|
| Blood Loss, Surgical | 3 | 2013 | 112 | 0.080 |
Why?
|
| S-Nitrosoglutathione | 1 | 2007 | 10 | 0.080 |
Why?
|
| Enteric Nervous System | 1 | 2007 | 8 | 0.080 |
Why?
|
| Morbidity | 1 | 2007 | 148 | 0.080 |
Why?
|
| Colonic Diseases | 1 | 2007 | 65 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2013 | 1376 | 0.070 |
Why?
|
| Astrocytes | 1 | 2007 | 139 | 0.070 |
Why?
|
| Incidence | 3 | 2014 | 1576 | 0.070 |
Why?
|
| Wound Healing | 2 | 2014 | 344 | 0.070 |
Why?
|
| Colon | 3 | 2013 | 496 | 0.070 |
Why?
|
| Analysis of Variance | 3 | 2007 | 912 | 0.070 |
Why?
|
| Prognosis | 4 | 2017 | 3674 | 0.060 |
Why?
|
| Postoperative Period | 1 | 2005 | 303 | 0.060 |
Why?
|
| Diagnostic Errors | 1 | 2005 | 160 | 0.060 |
Why?
|
| Aged, 80 and over | 4 | 2000 | 6501 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 1 | 2005 | 552 | 0.060 |
Why?
|
| Surgical Wound Infection | 2 | 2014 | 184 | 0.060 |
Why?
|
| Neoadjuvant Therapy | 1 | 2005 | 317 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 1673 | 0.060 |
Why?
|
| Operative Time | 2 | 2013 | 127 | 0.050 |
Why?
|
| Intestinal Neoplasms | 1 | 2001 | 56 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2004 | 1801 | 0.050 |
Why?
|
| Rectovaginal Fistula | 1 | 2000 | 7 | 0.050 |
Why?
|
| Peristalsis | 1 | 2000 | 10 | 0.050 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2003 | 237 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2014 | 999 | 0.050 |
Why?
|
| Rectal Fistula | 1 | 2000 | 18 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2008 | 2261 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2003 | 454 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 1384 | 0.040 |
Why?
|
| Ileum | 1 | 2000 | 159 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2007 | 2501 | 0.040 |
Why?
|
| Hepatectomy | 1 | 2000 | 166 | 0.040 |
Why?
|
| Postoperative Care | 1 | 2000 | 221 | 0.040 |
Why?
|
| Methods | 1 | 1998 | 152 | 0.040 |
Why?
|
| Duodenum | 1 | 1998 | 100 | 0.040 |
Why?
|
| Acute Disease | 1 | 1998 | 826 | 0.040 |
Why?
|
| Metronidazole | 1 | 1996 | 26 | 0.040 |
Why?
|
| Ciprofloxacin | 1 | 1996 | 29 | 0.040 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 1996 | 38 | 0.030 |
Why?
|
| Dehydration | 1 | 2015 | 18 | 0.030 |
Why?
|
| Intraabdominal Infections | 1 | 2015 | 10 | 0.030 |
Why?
|
| Tissue Adhesions | 1 | 1995 | 50 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 1996 | 89 | 0.030 |
Why?
|
| Ulcer | 1 | 2014 | 36 | 0.030 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2014 | 37 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2015 | 303 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2015 | 399 | 0.030 |
Why?
|
| Tight Junctions | 1 | 2015 | 149 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2000 | 735 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2014 | 291 | 0.030 |
Why?
|
| Conversion to Open Surgery | 1 | 2013 | 11 | 0.030 |
Why?
|
| Rectal Diseases | 1 | 2013 | 24 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2011 | 2767 | 0.030 |
Why?
|
| Infliximab | 1 | 2013 | 151 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 2013 | 393 | 0.030 |
Why?
|
| Algorithms | 1 | 2000 | 1830 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1197 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 273 | 0.030 |
Why?
|
| Prevalence | 1 | 2016 | 1239 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2013 | 476 | 0.030 |
Why?
|
| Chicago | 1 | 2016 | 1379 | 0.030 |
Why?
|
| Intestinal Perforation | 1 | 2011 | 34 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 504 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 1995 | 556 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2015 | 413 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2013 | 352 | 0.020 |
Why?
|
| Child | 2 | 2003 | 6926 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 689 | 0.020 |
Why?
|
| Inflammation | 1 | 1996 | 920 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2015 | 1823 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 1992 | 297 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2006 | 1019 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 712 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2013 | 329 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 307 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1996 | 1313 | 0.020 |
Why?
|
| Logistic Models | 1 | 2013 | 1185 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2017 | 1464 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 1753 | 0.020 |
Why?
|
| Fecal Incontinence | 1 | 2008 | 57 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 1804 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2008 | 173 | 0.020 |
Why?
|
| Age Distribution | 1 | 2008 | 204 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 977 | 0.020 |
Why?
|
| Probability | 1 | 2008 | 355 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 1621 | 0.020 |
Why?
|
| Zonula Occludens-2 Protein | 1 | 2007 | 11 | 0.020 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2007 | 24 | 0.020 |
Why?
|
| Norethindrone | 1 | 2007 | 12 | 0.020 |
Why?
|
| Observation | 1 | 2007 | 37 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2008 | 272 | 0.020 |
Why?
|
| Dextrans | 1 | 2007 | 77 | 0.020 |
Why?
|
| Occludin | 1 | 2007 | 66 | 0.020 |
Why?
|
| Italy | 1 | 2007 | 106 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2017 | 3241 | 0.020 |
Why?
|
| Japan | 1 | 2007 | 307 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2007 | 224 | 0.020 |
Why?
|
| Dogs | 1 | 2007 | 685 | 0.020 |
Why?
|
| Estradiol | 1 | 2007 | 252 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 376 | 0.020 |
Why?
|
| Epithelium | 1 | 2007 | 319 | 0.020 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2005 | 41 | 0.020 |
Why?
|
| Testosterone | 1 | 2007 | 271 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2007 | 782 | 0.020 |
Why?
|
| Short Bowel Syndrome | 1 | 2005 | 37 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2008 | 970 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 927 | 0.020 |
Why?
|
| Actins | 1 | 2007 | 451 | 0.010 |
Why?
|
| Biopsy | 1 | 2007 | 1161 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2007 | 1540 | 0.010 |
Why?
|
| Laparotomy | 1 | 2003 | 59 | 0.010 |
Why?
|
| RNA | 1 | 2007 | 560 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2005 | 857 | 0.010 |
Why?
|
| Gene Expression | 1 | 2007 | 1284 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2005 | 408 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 2818 | 0.010 |
Why?
|
| Rats | 1 | 2007 | 3990 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2007 | 1196 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2003 | 864 | 0.010 |
Why?
|
| Age Factors | 1 | 2003 | 1849 | 0.010 |
Why?
|
| Survival Rate | 1 | 2000 | 1860 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2000 | 1937 | 0.010 |
Why?
|
| United States | 1 | 2007 | 6665 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 11352 | 0.010 |
Why?
|
| Animals | 1 | 2007 | 26581 | 0.000 |
Why?
|